BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cancino-Marentes ME, Hernández-Flores G, Ortiz-Lazareno PC, Villaseñor-García MM, Orozco-Alonso E, Sierra-Díaz E, Solís-Martínez RA, Cruz-Gálvez CC, Bravo-Cuellar A. Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line. BMC Urol 2021;21:38. [PMID: 33711972 DOI: 10.1186/s12894-021-00807-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Hashemi M, Zandieh MA, Talebi Y, Rahmanian P, Shafiee SS, Nejad MM, Babaei R, Sadi FH, Rajabi R, Abkenar ZO, Rezaei S, Ren J, Nabavi N, Khorrami R, Rashidi M, Hushmandi K, Entezari M, Taheriazam A. Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies. Biomed Pharmacother 2023;160:114392. [PMID: 36804123 DOI: 10.1016/j.biopha.2023.114392] [Reference Citation Analysis]
2 Cruz-gálvez CC, Ordaz-favila JC, Villar-calvo VM, Cancino-marentes ME, Bosch-canto V. Retinoblastoma: Review and new insights. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.963780] [Reference Citation Analysis]